Red yeast nice stimulates bone formation in rats

被引:18
作者
Gutierrez, Gloria E. [1 ]
Benjamin, Mundy
Rossini, Gianni
Garrett, I. Ross
Chen, Stephen T.
Mundy, Gregory R.
机构
[1] OsteoScreen Ltd, San Antonio, TX 78229 USA
[2] STC Int Inc, Santa Clara, CA 95051 USA
[3] Marathon Nutrifoods LP, San Antonio, TX 78229 USA
关键词
red yeast rice; statins; osteoporosis; HMG-CoA inhibitors; bone anabolic activity; rats;
D O I
10.1016/j.nutres.2006.02.006
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Statins are a class of drugs commonly prescribed to decrease cholesterol levels that have recently been shown to also stimulate bone formation. Clinical data have emerged in the last few years that suggest statins may reduce the risk of fracture in patients taking these drugs for cholesterol lowering. Red yeast rice (RYR), rice that has been fermented by the red yeast Monascus purpureus, is frequently used in Chinese cuisine to flavor Peking duck and has also been used in traditional medicinal therapy in Asia for centuries. It has been reported that certain strains of RYR produce sufficient levels of lovastatin and other related statins to lower cholesterol levels when ingested by patients with hyperlipidemia. These findings may explain, in part, the suggested benefits of treating heart disease with RYR in conventional Chinese medicine. Because of the bone anabolic effect of statins, we hypothesized that RYR may also be capable of stimulating bone formation. We evaluated several different strains of RYR and identified strains that contained a natural form of lovastatin. These lovastatin-containing strains were shown to produce strong bone anabolic effects both in vitro and in vivo, indicating a potential application of RYR as a therapy for bone loss in conditions such as osteoporosis. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 30 条
[1]  
Bauer DC, 1999, J BONE MINER RES, V14, pS179
[2]   Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women [J].
Chan, KA ;
Andrade, SE ;
Boles, M ;
Buist, DSM ;
Chase, GA ;
Donahue, JG ;
Goodman, MJ ;
Gurwitz, JH ;
LaCroix, AZ ;
Platt, R .
LANCET, 2000, 355 (9222) :2185-2188
[3]   Oral statins and increased bone-mineral density in postmenopausal women [J].
Edwards, CJ ;
Hart, DJ ;
Spector, TD .
LANCET, 2000, 355 (9222) :2218-2219
[4]   MONACOLIN-K, A NEW HYPOCHOLESTEROLEMIC AGENT PRODUCED BY A MONASCUS SPECIES [J].
ENDO, A .
JOURNAL OF ANTIBIOTICS, 1979, 32 (08) :852-854
[5]  
Garrett IR, 2000, J BONE MINER RES, V15, pS225
[6]  
Garrett IR, 2003, METH MOLEC MED, V80, P183
[7]   Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro [J].
Garrett, IR ;
Chen, D ;
Gutierrez, G ;
Zhao, M ;
Escobedo, A ;
Rossini, G ;
Harris, SE ;
Gallwitz, W ;
Kim, KB ;
Hu, S ;
Crews, CM ;
Mundy, GR .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (11) :1771-1782
[8]   TISSUE SELECTIVITY OF THE CHOLESTEROL-LOWERING AGENTS LOVASTATIN, SIMVASTATIN AND PRAVASTATIN IN RATS INVIVO [J].
GERMERSHAUSEN, JI ;
HUNT, VM ;
BOSTEDOR, RG ;
BAILEY, PJ ;
KARKAS, JD ;
ALBERTS, AW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 158 (03) :667-675
[9]  
Gutierrez G, 2000, J BONE MINER RES, V15, pS427
[10]  
Heber D, 1999, AM J CLIN NUTR, V69, P231